Mycolactone Diffuses from Mycobacterium ulcerans–Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid Organs
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Buruli ulcer (BU) is a progressive disease of subcutaneous tissues caused by Mycobacterium ulcerans. The pathology of BU lesions is associated with the local production of a diffusible substance, mycolactone, with cytocidal and immunosuppressive properties. The defective inflammatory responses in BU lesions reflect these biological properties of the toxin. However, whether mycolactone diffuses from infected tissues and suppresses IFN-gamma responses in BU patients remains unclear. METHODOLOGY/PRINCIPAL FINDINGS: Here we have investigated the pharmacodistribution of mycolactone following injection in animal models by tracing a radiolabeled form of the toxin, and by directly quantifying mycolactone in lipid extracts from internal organs and cell subpopulations. We show that subcutaneously delivered mycolactone diffused into mouse peripheral blood and accumulated in internal organs with a particular tropism for the spleen. When mice were infected subcutaneously with M. ulcerans, this led to a comparable pattern of distribution of mycolactone. No evidence that mycolactone circulated in blood serum during infection could be demonstrated. However, structurally intact toxin was identified in the mononuclear cells of blood, lymph nodes and spleen several weeks before ulcerative lesions appear. Importantly, diffusion of mycolactone into the blood of M. ulcerans-infected mice coincided with alterations in the functions of circulating lymphocytes. CONCLUSION: In addition to providing the first evidence that mycolactone diffuses beyond the site of M. ulcerans infection, our results support the hypothesis that the toxin exerts immunosuppressive effects at the systemic level. Furthermore, they suggest that assays based on mycolactone detection in circulating blood cells may be considered for diagnostic tests of early disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence
George, K. M., Chatterjee, D., Gunawardana, G., Welty, D., Hayman, J., Lee, R., & Small, P. L. C. (1999) · Science · doi:10.1126/science.283.5403.854 · Cited by 641
Cited by
Ecology and Transmission of Buruli Ulcer Disease: A Systematic Review
Merritt, R. W., Walker, E. D., Small, P. L. C., Wallace, J. R., Johnson, P. D. R., Benbow, M. E., & Boakye, D. A. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000911 · Cited by 328
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans
Demangel, C., Stinear, T. P., & Cole, S. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2077 · Cited by 197
“ulcerans , but not with a mycolactone-deficient mutan”
BackgroundSelf-citationHall, B. S., Hill, K., McKenna, M., Ogbechi, J., High, S., Willis, A. E., & Simmonds, R. E. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004061 · Cited by 162
“In ulcerated lesions, where large amounts of mycolactone are produced by foci of extracellular bacilli, inflammatory cell infiltration is limited to the periphery [9–11].”
BackgroundMycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism
Simmonds, R. E., Lali, F. V., Smallie, T., Small, P. L. C., & Foxwell, B. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802294 · Cited by 106
“However, recently mycolactone was shown to be present in the PBMCs of BU patients (41).”
BackgroundBuruli Ulcer: Advances in Understanding Mycobacterium ulcerans Infection
Walsh, D. S., Portaels, F., & Meyers, W. M. (2011) · Dermatologic Clinics · doi:10.1016/j.det.2010.09.006 · Cited by 88
Metadata
- Authors
- Hong, H., Coutanceau, E., Leclerc, M., Caleechurn, L., Leadlay, P. F., & Demangel, C.
- Venue
- PLoS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-10-22
- Volume
- 2
- Issue
- 10
- Pages
- e325
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W2062815165
- Cited by
- 92
- References
- 1
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.